BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2013
View Archived Issues
Neumedicines receives BARDA intent to exercise contract option on HemaMax
Read More
Researchers prepare neuraminidase inhibitor prodrug for influenza
Read More
PI3Kdelta inhibition delays the progression of autoimmune diabetes
Read More
Eisai profiles progress of fiscal 2012
Read More
Fluorinated enigmol analogues demonstrate oncolytic activity in vivo
Read More
Researchers present first PET radiotracers targeting SV2
Read More
New antimicrobial development strategy to minimize acquired drug resistance
Read More
AstraZeneca designs matched triplicate approach for optimization of drug pharmacokinetics
Read More
Dosing completed in phase I TTI-1612 study
Read More
Aridis Pharmaceuticals acquires anti-infective MAb products from Kenta Biotech
Read More
Northwest Biotherapeutics begins phase III DCVax-L brain cancer trial in Europe
Read More
Daiichi Sankyo highlights progress of fiscal 2012
Read More
Merck & Co. discloses new GPR131 receptor agonists
Read More
A novel mGlur5PV-/- mouse model of schizophrenia shows altered sensorimotor gating
Read More
Merck & Co. prepares novel orexin receptor antagonists
Read More
New ROMK blockers disclosed by Merck & Co.
Read More
DBV Technologies and Stallergenes collaborate on respiratory allergy therapy
Read More
Allergan divulges novel FPRL1 ligands
Read More
SciClone and Zensun sign licensing agreement for Chinese rights to Neucardin
Read More
Researchers at Merck Frosst Canada patent new agents for HIV infection
Read More
RuiYi and Genor BioPharma sign agreement for anti-IL-6 antibody in China
Read More
Roche prepares new CB2 receptor agonists
Read More
Bayer to acquire Steigerwald
Read More